Alerts

Mojo Risen capsules pose a serious risk to your health and should not be taken. They contain undeclared tadalafil and have not been assessed for quality, safety or efficacy.

Maxman III capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and have not been assessed for quality, safety or efficacy.

Ziyinzhuangyang tablets pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and have not been assessed for quality, safety or efficacy.

Health professionals and consumers are advised that Abbott Diabetes Care, after consultation with the TGA, has initiated a recall for product correction for its FreeStyle InsuLinx Blood Glucose Meter.

Health professionals and consumers are advised that Alcon Laboratories Australia, in consultation with the TGA, has issued a hazard alert regarding AcrySof Cachet Phakic Lenses.

Health professionals and consumers are advised that Hoya Surgical Optics, in consultation with the TGA, is recalling certain Hoya One-Piece Intraocular Lenses (IOLs) that are in the supply chain.

Health professionals and consumers are advised that Johnson & Johnson Medical Pty Ltd, after consultation with the TGA, is recalling its OneTouch Verio IQ Blood Glucose Meter.

Health professionals and consumers are advised that selected lots of AMS 800 Control Pumps may not function as intended by the manufacturer, American Medical Systems Inc (AMS).

Paiyouji Natural Slimming Capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and phenolphthalein, which is associated with serious safety concerns.

Health professionals and patients are advised that a review of post-market surveillance data has identified that the Adept 12/14 Modular Head has a higher-than-expected revision rate.

Health professionals and consumers are advised that sponsor, Sorin Group Australia, in consultation with the TGA, has issued a hazard alert for Isoline defibrillation leads.

Precautionary product notification for GlaxoSmithKline Australia (GSK) influenza vaccine, Fluarix

Safety alert: TGA warns that GNY Australia MSV Strong, ESV Extra Strong, and RL Rapid Loss capsules contain undeclared sibutramine (a banned prescription drug linked to serious heart risks), making them unsafe, illegal, and potentially harmful; consumers should stop use immediately. [tga.gov.au]

My Slimmer Me (MSM) soft gel capsules pose a serious risk to your health and should not be taken. They contain undeclared sibutramine. This increases the risk of major cardiac events.

About seasonal flu vaccine: 2013 seasonal influenza vaccines for use in children

Natural Miaotiaoyishen capsules pose a serious risk to your health and should not be taken. They contain undeclared sibutramine and phenolphthalein. Both substances have serious safety concerns.

Updated information regarding patient follow-up for the ABGII Modular Femoral Stem and Modular Neck hip replacement system.

Poly Implant Prothèse (PIP) update

The TGA has performed and reported on a large number of tests on the chemical properties, physical properties and the biological safety of the gels and shells of PIP breast implants.

TGA safety alert warning that Albuterex Xtreme, Albutarex Xtreme and Albutarex Femme Formula contain undeclared prescription substances and high caffeine levels, posing serious health risks and are subject to recall.

Libigirl capsules pose a serious risk to your health and should not be taken. It contains undeclared sildenafil and tadalafil and has not been assessed by the TGA for quality, safety or efficacy.

Meizi Evolution Botanical Slimming soft gel capsules pose a serious risk to your health and should not be taken. They contain undeclared sibutramine. This increases the risk of major cardiac events.

Best Slim capsules pose a serious risk to your health and should not be taken. They contain the undeclared substance sibutramine. This increases the risk of major cardiac events.

PIP breast implants: Consumer questions & answers

GlaxoSmithKline (GSK) and Alphapharm, in consultation with the TGA, are undertaking a voluntary recall of several batches of Ventolin and Asmol inhalers due to a fault in the delivery mechanism of a small number of inhalers within each batch. This can lead to less than the full dose being delivered for each puff.